Form EFFECT Cidara Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005780 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Newport Beach Rehab Cites Client Reviews on Gender-Specific Care
- As U.S. Markets Power to Historic All-Time Highs, Reminiscent of the Dot-Com Boom Era, ELEKTROS Inc. Celebrates a 10% Friday Gain While Advancing a Bold Long-Term Vision for Shareholders
- Emdoor Launches "Ailyn" AI Hub at WAIC 2026: Unifying Intelligence Across Every Device
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
